* Ekso Bionics Holdings Inc EKSO.OQ EKSO.O is expected
to show
a rise in quarterly revenue when it reports results on November
3.
* The San Rafael California California-based company is
expected
to report a 17.5% increase in revenue to $3.583 million from
$3.05 million a year ago, according to the estimate from one
analyst, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Ekso Bionics
Holdings Inc
is for a loss of 24 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Ekso
Bionics
Holdings Inc is $9, above its last closing price of $1.66.
This summary was machine generated November 1 at 23:34 GMT. All
figures in US dollars unless otherwise stated